Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: Results from a cohort study

Inflammation Research

Volumn 60, Issue 3, 2011, Pages 289-297

  Ojeda Ojeda, Miriam ^a,d   Larrondo Muguercia, Hilev ^b   Magdariaga Figuerola, Abel ^a   Sánchez Valdivia, Alfredo ^b   Rodríguez Alonso, Ingrid ^a   Valenzuela Silva, Carmen ^a   García Iglesias, Elizeth ^a   Domínguez Alonso, Emma ^d   Buurman, Wim A ^c   Araña Rosaínz, Manuel De Jesús ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d INSTITUTO NACIONAL DE ENDOCRINOLOGÍA   (Cuba)

Author keywords

Cytokines; Intensive care; Markers; Peritonitis; Sepsis

Indexed keywords

INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EX VIVO STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LYMPHOCYTE COUNT; MALE; MULTIPLE ORGAN FAILURE; PERITONITIS; PNEUMONIA; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SURVIVOR;

ABDOMINAL CAVITY; ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS INFECTION; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79951727549     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0267-4     Document Type: Article

References (31)

1. RC Bone RA Balk FB Cerra RP Dellinger AM Fein WA Knaus, et al. 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644 1655 1:STN:280:DyaK383ovFeiuw%3D%3D 10.1378/chest.101.6.1644 1303622
2. JL Vincent FB de Carvalho D de Backer 2002 Management of septic shock Ann Med 34 606 613 1:CAS:528:DC%2BD3sXhs1Wgu74%3D 10.1080/078538902321117832 12553501 (Pubitemid 36113820)
3. C Pierrakos JL Vincent 2010 Sepsis biomarkers: a review Crit Care 14 R15 R33 10.1186/cc8872 20144219
4. JC Marshall JL Vincent MP Fink DJ Cook G Rubenfeld D Foster, et al. 2003 Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000 Crit Care Med 31 1560 1567 10.1097/01.CCM.0000065186.67848. 3A 12771633 (Pubitemid 36583875)
5. SK Tschoeke W Ertel 2007 Immunoparalysis after multiple trauma Injury 38 1346 1357 10.1016/j.injury.2007.08.041 18048039 (Pubitemid 350192400)
6. MD Menger B Vollmar 2004 Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 389 475 484 10.1007/s00423-004-0472-0 15173946 (Pubitemid 40022444)
7. S Endo K Inada Y Yamada T Takakuwa H Nakae T Kasai, et al. 1996 Functional modification of vascular endothelial cells by cytokines during septic shock Res Commun Mol Pathol Pharmacol 94 23 38 1:CAS:528:DyaK28XnsVWrt7w%3D 8948012
8. MK Angele E Faist 2002 Clinical review: immunodepression in the surgical patient and increased susceptibility to infection Crit Care 6 298 305 10.1186/cc1514 12225603 (Pubitemid 34863695)
9. Y Arabi N Al Shirawi Z Memish S Venkatesh A Al-Shimemeri 2003 Assessment of six mortality prediction models in patients admitted with severe sepsis and septic shock to the intensive care unit: a prospective cohort study Crit Care 7 R116 R122 10.1186/cc2373 12974979
10. I Engelberts A Moller GJ Schoen CJ van der Linden WA Buurman 1991 Evaluation of measurement of TNFα in plasma by ELISA Lymphokine Cytokine Res 10 69 76 1:CAS:528:DyaK3MXksVOgt7k%3D 1873359
11. MA Dentener V Bazil EJ von Asmuth M Ceska WA Buurman 1993 Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages J Immunol 150 2885 2891 1:CAS:528:DyaK3sXktVKqsro%3D 7681082 (Pubitemid 23127537)
12. 15N]nitrate in biological fluids Anal Biochem 126 131 138 1:CAS:528:DyaL38XlvFGgtLY%3D 10.1016/0003-2697(82) 90118-X 7181105 (Pubitemid 13203451)
13. JR Le Gall S Lemeshow F Saulnier 1993 A new Simplified Acute Physiology Score (SAPS-II) based on a European/North American multicenter study JAMA 270 2957 2963 1:STN:280:DyaK2c%2Fns1GmtA%3D%3D 10.1001/jama.270.24.2957 8254858 (Pubitemid 24000804)
14. JL Vincent R Moreno J Takala S Willatts A De Mendonca H Bruining, et al. 1996 The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine Intensive Care Med 22 707 710 1:STN:280:DyaK2s%2FgtFantQ%3D%3D 10.1007/BF01709751 8844239
15. ØA Strand A Leone KE Giercksky KA Kirkebøen 2000 Nitric oxide indices in human septic shock Crit Care Med 28 2779 2785 1:CAS:528:DC%2BD3MXjvVeqtL8%3D 10.1097/00003246-200008000-00017 10966250
16. W Heagy K Nieman C Hansen M Cohen D Danielson MA West 2003 Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients Surg Infect 4 171 180 10.1089/109629603766956960 (Pubitemid 37038783)
17. FC Riche BP Cholley YH Panis MJ Laisne CG Briard AM Graulet, et al. 2000 Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis Crit Care Med 28 433 437 1:STN:280: DC%2BD3c7ntVCmsA%3D%3D 10.1097/00003246-200002000-00024 10708179 (Pubitemid 30120885)
18. GM Albaiceta PR Pedreira E García-Prieto F Tabeada 2007 Therapeutic implications of immunoparalysis in critically ill patients Inflamm Allergy Drug Target 6 191 196 1:CAS:528:DC%2BD1cXntFahu7c%3D 10.2174/187152807783334337
19. AC Lukaszewicz M Grienay M Resche-Rigon R Pirracchio V Faivre B Boval, et al. 2009 Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction Crit Care Med 37 2746 2752 1:CAS:528:DC%2BD1MXhtFGgu7fL 10.1097/CCM.0b013e3181ab858a 19707128
20. T Daniel M Alexander WJ Hubbard IH Chaudry MA Choudhry MG Schwacha 2006 Nitric oxide contributes to the development of a post-injury Th2 T-cell phenotype and immune dysfunction J Cell Physiol 208 418 427 1:CAS:528: DC%2BD28XmvVKitrg%3D 10.1002/jcp.20677 16642464 (Pubitemid 43993432)
21. C Chen WH Lee L Zhong CP Liu 2006 Regulatory T cells can mediate their function through the stimulation of APCs to produce immunosuppressive nitric oxide J Immunol 176 3449 3460 1:CAS:528:DC%2BD28XitVSkt7k%3D 16517713 (Pubitemid 43363992)
22. A Cauwels 2007 Nitric oxide in shock Kidney Int 72 557 565 1:CAS:528:DC%2BD2sXpsVartrk%3D 10.1038/sj.ki.5002340 17538569 (Pubitemid 47312788)
23. JM Cavaillon C Adrie C Fitting M Adib-Conquy 2003 Endotoxin tolerance: is there a clinical relevance? J Endotoxin Res 9 101 107 1:CAS:528: DC%2BD3sXksl2lsb0%3D 12803883 (Pubitemid 36603684)
24. A Draisma M Dorresteijn P Pickkers H van der Hoeven 2008 The effect of systemic iNOS inhibition during human endotoxemia on the development of tolerance to different TLR-stimuli Innate Immun 14 153 159 1:CAS:528: DC%2BD1cXovVGjs70%3D 10.1177/1753425908091959 18562574
25. MB Dias MC Almeida EC Carnio LGS Branco 2005 Role of nitric oxide in tolerance to lipopolysaccharide in mice J Appl Physiol 98 1322 1327 1:CAS:528:DC%2BD2MXjt1WgsLo%3D 10.1152/japplphysiol.01243.2004 15579566 (Pubitemid 40396506)
26. C Mitaka Y Hirata K Yokoyama H Wakimoto M Hirokawa T Nosaka, et al. 2003 Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response Shock 19 305 309 1:CAS:528:DC%2BD2cXivFGrsbg%3D 10.1097/00024382-200304000-00002 12688539
27. AR Novotny K Emmanuel S Maier A Westerholt H Weighardt J Stadler, et al. 2007 Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome Surgery 141 376 384 10.1016/j.surg.2006.08.011 17349850 (Pubitemid 46356439)
28. B Hauser H Bracht M Matejovic P Radermacher B Venkatesh 2005 Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies Anesth Analg 101 488 498 1:CAS:528:DC%2BD2MXmtlOms7k%3D 10.1213/01.ANE.0000177117. 80058.4D 16037166 (Pubitemid 41045235)
29. A López JA Lorente J Steingrub J Bakker A McLuckie S Willatts, et al. 2004 Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock Crit Care Med 32 21 30 10.1097/01.CCM.0000105581.01815.C6 14707556 (Pubitemid 38125559)
30. I de Werra C Jaccard SB Corradin R Chiolero B Yersin H Gallati, et al. 1997 Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia Crit Care Med 25 607 613 10.1097/00003246-199704000-00009 9142024 (Pubitemid 27193972)
31. JR Le Gall A Neumann F Hemery JP Bleriot JP Fulgencio B Garrigues, et al. 2005 Mortality prediction using SAPS II: an update for French intensive care units Crit Care 9 R645 R652 10.1186/cc3821 16280063